Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

25 Jan 2019 07:00

RNS Number : 0641O
Barr(A.G.) PLC
25 January 2019
 

 

 

IMMEDIATE RELEASE 25 January 2019

A.G. BARR p.l.c.

("A.G. BARR")

Trading Update

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a pre-close trading update in respect of the financial year (52 weeks) ending 26 January 2019.

 

We are pleased to report a continued positive trading performance across the period with revenue expected to be c.£277m, up c.5% on the prior year (2017/18 : £264.1m1).

 

Strong trading execution across our core brands and the continued success of our key innovation have led to further market share volume gains in a UK soft drinks market which saw volume up 3.0% while value increased by 8.0% (Source : IRI Marketplace 48 weeks to 30 December 2018).

 

The impact of the Soft Drinks Industry Levy has been evident across the UK soft drinks market with value growth significantly outstripping volume in the period. Having taken the opportunity to drive our volume growth during this period, we expect to return to a more value-led trading strategy in 2019.

 

Throughout the year we have remained committed to investing across our brands, assets and people which, while supporting our growth, has had a moderate impact on operating margin.

 

Our tight control on costs has been maintained and our balance sheet remains robust. The £30m share repurchase programme has continued and we now expect it to complete during the course of 2019, slightly later than previously indicated.

 

For the financial year ending 26 January 2019, we remain confident of delivering profit ahead of the prior year and in line with the Board's expectations.

 

Outlook

Looking ahead, the current political and economic uncertainty in the UK looks set to continue. For the soft drinks industry, further regulatory intervention is on the horizon and consumer dynamics continue to evolve. Our strong and flexible business model, our portfolio of differentiated and growing brands and our well-invested and efficient asset base give us confidence for continued profitable growth as we enter a new financial year.

 

A.G. BARR intends to announce its full year financial results on 26 March 2019.

 

For further information, please contact:

 

A.G. BARR

Tel: 0330 390 3900

Roger White, Chief Executive

Stuart Lorimer, Finance Director

 

Instinctif Partners

Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

 

1 All numbers reflect the adoption of IFRS 15 "Revenue from Contracts with Customers". Certain costs payable to customers, previously presented as expenses, are now shown as a deduction to revenue. There has been a £13.6m restatement to the prior year to enable an accurate comparison of performance.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEAXFLADDNEFF
Date   Source Headline
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update
11th Jan 202211:28 amRNSDirector/PDMR Shareholding
8th Dec 202112:59 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSInvestment in MOMA Foods Limited
29th Nov 20217:00 amRNSTrading Update
8th Nov 20212:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20211:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20219:37 amRNSDirector/PDMR Shareholding
1st Nov 202112:50 pmRNSDirector/PDMR Shareholding
11th Oct 20212:15 pmRNSDirector/PDMR Shareholding
11th Oct 20218:12 amRNSDirector/PDMR Shareholding
1st Oct 20218:49 amRNSDirector/PDMR Shareholding
1st Oct 20218:33 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim results
8th Sep 202111:39 amRNSDirector/PDMR Shareholding
31st Aug 202110:37 amRNSNotice of Interim Results Date
9th Aug 202111:21 amRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSH1 trading update to 1 August 2021
20th Jul 20217:00 amRNSTrading Update
19th Jul 20212:22 pmRNSHolding(s) in Company
9th Jul 20217:55 amRNSDirector/PDMR Shareholding
6th Jul 20213:32 pmRNSDirector/PDMR Shareholding - AMENDMENT
6th Jul 202112:11 pmRNSDirector/PDMR Shareholding
25th Jun 20217:00 amRNSDirectorate Changes
10th Jun 20219:01 amRNSHolding(s) in Company
8th Jun 20213:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.